Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
FibroGen, Inc (FGEN) had Normalized Income after Taxes of $-84.87M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$-123.25M |
|
$17.98M |
|
$-20.66M |
|
$-102.59M |
|
$-31.60M |
|
$-91.66M |
|
$6.73M |
|
$-84.92M |
|
$-84.92M |
|
$-84.87M |
|
$-87.54M |
|
$17.98M |
|
|
Normalized Income after Taxes |
$-84.87M |
$-91.66M |
|
$-91.30M |
|
100.04M |
|
100.04M |
|
$0.18 |
|
$0.18 |
|
| Balance Sheet Financials | |
$196.51M |
|
-- |
|
$18.02M |
|
$214.53M |
|
$133.31M |
|
$73.09M |
|
$286.33M |
|
$419.64M |
|
$-205.12M |
|
$-205.12M |
|
$-205.12M |
|
100.92M |
|
| Cash Flow Statement Financials | |
$-138.00M |
|
$125.99M |
|
$-0.26M |
|
$113.69M |
|
$102.18M |
|
$-11.51M |
|
$25.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.47 |
|
-- |
|
-- |
|
-0.55 |
|
-0.36 |
|
83.23% |
|
74.36% |
|
74.36% |
|
-- |
|
68.90% |
|
-14.59% |
|
$-137.22M |
|
-- |
|
-- |
|
-- |
|
-0.57 |
|
-6.55 |
|
-256.25 |
|
-0.35 |
|
42.68% |
|
42.68% |
|
-40.80% |
|
66.30% |
|
$-2.03 |
|
$-1.37 |
|
$-1.38 |
|